Cell-based Assays Market (By Product & Services: Microplate, Reagents, Assay Kits, Cell Lines, Instruments & Services; By Application; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cell-based Assays Market 

5.1. COVID-19 Landscape: Cell-based Assays Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cell-based Assays Market, By Product

8.1. Cell-based Assays Market, by Product, 2022-2030

8.1.1 Consumable

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Assay Kits

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Cell Lines

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Service

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Instrument

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Cell-based Assays Market, By End-user

9.1. Cell-based Assays Market, by End-user, 2022-2030

9.1.1. Pharmaceutical & Biotechnology Companies

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Contract Research Organizations

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Academic & Government Research Institutes

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Cell-based Assays Market, By Application 

10.1. Cell-based Assays Market, by Application, 2022-2030

10.1.1. Drug Discovery

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. ADME Studies

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Basic Research

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Predictive Toxicology

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Cell-based Assays Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.2. Market Revenue and Forecast, by End-user (2017-2030)

11.1.3. Market Revenue and Forecast, by Application (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.4.2. Market Revenue and Forecast, by End-user (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2. Market Revenue and Forecast, by End-user (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.2. Market Revenue and Forecast, by End-user (2017-2030)

11.2.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.4.2. Market Revenue and Forecast, by End-user (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2. Market Revenue and Forecast, by End-user (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2. Market Revenue and Forecast, by End-user (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2. Market Revenue and Forecast, by End-user (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.2. Market Revenue and Forecast, by End-user (2017-2030)

11.3.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.4.2. Market Revenue and Forecast, by End-user (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2. Market Revenue and Forecast, by End-user (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2. Market Revenue and Forecast, by End-user (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2. Market Revenue and Forecast, by End-user (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.2. Market Revenue and Forecast, by End-user (2017-2030)

11.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.4.2. Market Revenue and Forecast, by End-user (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2. Market Revenue and Forecast, by End-user (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2. Market Revenue and Forecast, by End-user (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2. Market Revenue and Forecast, by End-user (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.2. Market Revenue and Forecast, by End-user (2017-2030)

11.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.4.2. Market Revenue and Forecast, by End-user (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2. Market Revenue and Forecast, by End-user (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)

Chapter 12. Company Profiles

12.1. Novartis AG

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. BD

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Beckman Coulter, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Danaher

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. General Electric

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Merck KGaA

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Thermo Fisher Scientific, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Lonza

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Cell Signaling Technology, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Perkinelmer, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms